Organized in coordination between the University of Geneva Faculty of Medicine and the Geneva University Hospitals, Switzerland.
Program:
Wednesday December 7, 2022
11.30 – 13.00 : Registration
13.00 – 13.20 : Introduction
Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland
Cem Gabay, Faculty of Medicine, University of Geneva, Switzerland
Session I: Surveillance, models & biobanks – novel tools to fight virus emergence
Chairs: Jenna Kelly, University of Bern, Keith Harshman, Health 2030 Genome Center
13.25 – 13.45 :
Modeling emerging infectious diseases: The past, the present, and the future
Christian Althaus, University of Bern, Switzerland
13.50 – 14.10
Wastewater-based Infectious Disease Surveillance
Tanja Stadler, ETH Zürich, Switzerland
14.15 – 14.35
WHO BioHub: the pilot phase
Nicole Liechti, Spiez Laboratory, Switzerland
14.40 - 15.00
Influenza surveillance
David Wentworth, Centre for Disease Control and Prevention, USA (online)
15.00 – 15.15: Discussion
15.15 – 15.45 : Coffee Break
Session II: Poxviruses in the spotlight - Monkeypox and other orthopoxviruses
Chairs: Laurent Kaiser, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland, Meriem Bekliz, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva, Switzerland
15.45 – 16.05
The long and winding road to smallpox eradication
David Heymann, London School of Tropical Medicine & Hygiene, UK (online)
16.10 – 16.30
Waking up to monkeypox
Piero Olliaro, University of Oxford, UK
16.35 – 16.55
Uncovering the evolutionary history of variola virus using ancient DNA
Barbara Mühlemann, Charite University Hospital Berlin, Germany
17.00 – 17.20
A One Health approach of monkeypox in the Central African Republic
Emmanuel Nakoune, Institute Pasteur, Central African Republic
17.20 – 17.35 : Discussion
Evening lectures (Keynote)
17.40 – 18.00
Welcome note
Laurent Kaiser, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland Geneva University Hospitals, Switzerland
Alain Kolly, Geneva University Hospitals, Switzerland
Chairs: Volker Thiel, University of Bern; Manuel Schibler, University Hospitals of Geneva
18.00 - 18.30
The origin and genetic history of the plague: What we learn from ancient pandemics
Johannes Krause, Max Planck Institute for the Science of Human History, Jena and Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany (online)
18.30 -19.00
Covid-19 and beyond: Understanding emerging viral diseases and their public health impact globally
Maria van Kerkhove, World Health Organization, Geneva, Switzerland
Social program
19.00 : Apero Venue: Foyer Campus Biotech
Thursday December 8, 2022
Session I: Communication, misinformation & the infodemic
Chairs: Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland; Emma Hodcroft, University of Bern & Geneva
08.30 –08.50
The fight against infodemics
Sylvie Briand, World Health Organization, Geneva
08.55 - 09.15
Vaccine hesitancy
Heidi Larson, London School of Tropical Medicine & Hygiene, UK (online)
09.20 – 09.40
Three Ps in a Pandemic: On Trust and Truth
Kai Kupferschmidt, Science Journalist, Berlin
09.40 – 09.55: Discussion
10.00 – 10.30 : Coffee break
Session II: Panel Discussion
10.30 – 12.00
Science, policy & pandemics –Better prepared for the next crisis?
Panel members:
Matthias Egger, SNSF
Volker Thiel, Vetsuisse Bern
Tanja Stadler, ETH Zürich
Celine Gardiol, Federal Office of Public Health
Alexandra Calmy, Faculty of Medicine, University of Geneva and Geneva University Hospitals
12.00 – 13.00 : Lunch, Venue: Foyer, Campus Biotech
Session III: SARS-CoV-2 immunity: From cells and antibodies to populations
Chairs: Didier Trono, EPFL, Olha Puhach, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland
13.00 – 13.20
Seroprevalence of anti-SARS-CoV-2 antibodies in Geneva: a tale of two years
Maria Eugenia Zaballa, Geneva University Hospitals, Switzerland
13.25 - 13.45
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease
Lorenzo Subissi, World Health Organization, Switzerland
13.50 - 14.10
Locking the Entry Door of SARS-CoV-2, are Mucosal Antibodies the Key?
Benjamin Meyer, University of Geneva, Switzerland
14.15 – 14.35
Why are children less affected than adults by SARS-CoV-2 infection? An immunological perspective
Arnaud Didierlaurent, University of Geneva, Switzerland
14.35 – 14.50 : Discussion
14.50 – 15.20 : Coffee break
Session IV: Monoclonal antibodies & antiviral drugs against emerging viruses
Chairs: Caroline Tapparel, University of Geneva; Manel Essaidi-Laziosi, University of Geneva
15.20 – 15.40
Novel treatments against SARS-CoV-2
Alexandra Calmy, Geneva University Hospitals, Switzerland
15.45 - 16.05
Broad neutralization: linchpin for HIV vaccine development
Alexandra Trkola, University of Zurich, Switzerland
16.05 – 16.20 : Discussion
Session V: The tools to end outbreaks – from science to impact
Chairs: Arnaud Didierlaurent, University of Geneva; Philippe Le Mercier, Swiss Institute of Bioinformatics
16.20 – 16.40
Recoding viral genomes - development of a live-attenuated vaccine platform
Volker Thiel, University of Bern, Switzerland
16.45 – 17.05
Adapting public health to evolving science is critical to combat emerging pathogens: yet a constant source of failures
Gary Kobinger, University of Texas Medical Branch, US
17.10 – 17.30
Putting existing vaccines to use: Insights from a Hepatitis E Vaccine Study in South Sudan and Beyond
Andrew Azman, MSF, Geneva, Switzerland and MSF Switzerland & Johns Hopkins Bloomberg School of Public Health
17.30 - 17.45 : Discussion
17.45 – 17.55 : Mini-Break
Keynote lectures
Chairs: Arnaud L'Huillier, University Hospitals of Geneva; Ana Rita Conçalves Cabecinhas, University Hospitals of Geneva
17.55 - 18.25
Genomics in a pandemic
Emma Hodcroft, University of Bern and Geneva University Hospitals, Switzerland
18.30 - 19.00
The future of vaccines against respiratory viruses
Florian Krammer, Icahn School of Medicine at Mount Sinai, USA (online)
Social program
19.30 : Conference dinner, Bain des Pâquis, Geneva
Friday December 9, 2022
Session I: Post Covid – what to expect when the pandemic is over?
Chairs: Manuel Schibler, Geneva University Hospitals; Iris Najjar, Geneva University Hospitals
08.15 - 08.35
Post-COVID: a new reality or what’s next?
Mayssam Nehme, Geneva University Hospitals, Switzerland
08.40 – 09.00
Post Covid, the aftershock of the pandemic
Carmen Scheibenbogen, Charité University Hospital, Berlin (online)
09.00 – 09.10 : Discussion
Session II: Late breakers in emerging viruses
Chairs: Nikki Shindo, World Health Organization, Frédérique Jacquerioz-Bausch, University Hospitals of Geneva
09.15 - 09.35
Sudan Ebola virus outbreak in Uganda
Pierre Formenty, World Health Organization, Geneva, Switzerland
09.40 – 09.50 : Discussion
09.50 - 10.10: Coffee break
Chairs: Olivia Keiser, University of Geneva; Daniel Bausch, FIND, the global alliance for diagnostics
Out of the box: Emerging viruses , ethics and global responsibility
10.10 – 10.30 : Ethics in a pandemic
Samia Hurst, University of Geneva
10.35 - 10.55
Access and global responsibility in a pandemic
Maria Guevara, Medecins Sans Frontieres, Geneva, Switzerland
10.55 – 11.05 : Discussion
Session III: Climate change & a One Health Approach
Chairs: François Chappuis, Geneva University Hospitals; Rafael Ruiz De Castañeda, University of Geneva
11.05 – 11.25
Arboviral diseases & climate Change
Desiree LaBeaud, Stanford University School of Medicine, USA (online)
11.30 – 11.50
Emerging viruses form a veterinary perspective
Barbara Wieland, Institute of Virology and Immunology and University of Bern, Switzerland
11.55 – 12.05 : Discussion
Award lecture
12.05 – 12.15
Award Ceremony
Laurent Kaiser, Geneva University Hospitals, Switzerland
12.15 – 12.45
Award Lecture
Richard Neher, Biozentrum Basel
12.45 - 12.55
Closing Remarks & Farewell
Laurent Kaiser, Geneva University Hospitals, Switzerland
Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Switzerland
 |
 |